[1] Evans JL, Goldfine ID, Maddux BA, et al.Oxidative stress and stress-activated signaling pathways:A unifying hypothesis of type 2 diabetes[J].Endocr Rev, 2002, 23(5):599-622. [2] Houstis N, Rosen ED, Lander ES.Reactive oxygen species have a causal role in multiple forms of insulin resistance[J].Nature, 2006, 440(7086):944-948. [3] Song F, Jia W, Yao Y, et al.Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed type 2 diabetes[J].Clin Sci (Lond), 2007, 112(12):599-606. [4] Kaneto H, Katakami N, Kawamori D, et al.Involvement of oxidative stress in the pathogenesis of diabetes[J].Antioxid Redox Signal, 2007, 9(3):355-366. [5] Semple RK, Chatterjee VK, O'Rahilly S.PPAR gamma and human metabolic disease[J].J Clin Invest, 2006, 116(3):581-589. [6] Li G, Barrett EJ, BarrettMO, et al.Tumor necrosis factor-alpha induces insulin resistance in endothelial cells via a p38 mitogen-activated protein kinase-dependent pathway[J].Endocrinology, 2007, 148(7):3356-3363. [7] Meigs JB, Larson MG, Fox CS, et al.Association of oxidative stress, insulin resistance, and diabetes risk phenotypes: the Framingham Offspring Study[J].Diabetes Care, 2007, 30(10):2529-2535. [8] Wilson C, Vereshchagina N, Reynolds B, et al.Extracellular and subcellular regulation of the PI3K Akt cassette: new mechanisms for controlling insulin and growth factor signalling[J].Biochem Soc Trans, 2007, 35(2):219-221. [9] Honjo S, Yokote K, Fujishiro T, et al.Early amelioration of insulin resistance and reduction of interleukin-6 in Werner syndrome using pioglitazone[J].J Am Geriatr Soc, 2008, 56(1):173-174. [10] Teramoto T, Yamada N, Shirai K, et al.Effects of pioglitazone hydrochloride on Japanese patients with type 2 diabetes mellitus[J].J Atheroscler Thromb, 2007, 14(2):86-93. |